Airfinity | Newsroom, COVID-19 and Vaccines News Articles and Media

September 2022

August 2022

July 2022

press

BioNTech-Aktie, Bavarian Nordic-Aktie & Co: According to new estimates, demand for vaccines is increasing significantly (de)

Published by Finanzen

Jul 31, 2022

press

AstraZeneca ‘saved’ six million lives with Covid vaccine

Published by Evening Standard

Jul 29, 2022

press

3 Key Questions That Pfizer Will Answer This Week

Published by Nasdaq

Jul 27, 2022

press

China just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid

Published by Fortune

Jul 26, 2022

press

Pfizer’s anti-COVID pill — used by Biden — is expected to rake in $23.2 billion, but confusion and weak demand could cause supply glut

Published by Fortune

Jul 25, 2022

press

Slow patient uptake of Pfizer’s Covid drug hints at end to sales boom

Published by Financial Times

Jul 25, 2022

press

Weak Demand For Covid Antivirals Dampens Roaring Sales

Published by Forbes

Jul 25, 2022

press

Wasted vaccines, over a billion unused doses: expired doses donated to poor countries

Published by La Repubblica

Jul 21, 2022

press

After Q2 Significant Drop, Pfizer and Moderna COVID-19 Vaccine Revenues to Rebound

Published by PharmaBoardroom

Jul 21, 2022

press

Covid, vaccine decline and Pfizer and Moderna's accounts

Published by Fortune

Jul 20, 2022

press

Analysis: 1.1 billion doses of covid 19 vaccine may have been wasted

Published by MedWatch

Jul 19, 2022

press

Vaxzevria 73% effective at preventing Omicron-related infections after fourth dose, according to real world evidence study in Thailand

Published by AstraZeneca

Jul 18, 2022

press

Europe Can’t Shake Off Covid as Variant Fuels Summer Spike

Published by Bloomberg

Jul 16, 2022

press

Covid Vaccine Sales Projected to Pick Up After Steep Drop

Published by Bloomberg

Jul 15, 2022

press

A riskier approach to new vaccines will pay off

Published by Financial Times

Jul 15, 2022

press

Worst backslide in global vaccinations ‘in a generation,’ U.N. says

Published by The Washington Post

Jul 14, 2022

press

Which covid-19 vaccine saved the most lives in 2021?

Published by The Economist

Jul 13, 2022

press

China's COVID-19 vaccine exports saved 3m lives, says UK study

Published by CGTN

Jul 13, 2022

press

Vaxzevria shown in expert review to provide equally effective protection against COVID-19 hospitalisation and death as mRNA vaccines

Published by AstraZeneca

Jul 13, 2022

press

Astra’s Covid Vaccine Saved Over Six Million Lives in First Year

Published by Bloomberg

Jul 13, 2022

press

Monopolies Are Getting in the Way of mRNA Vaccines

Published by Scientific American

Jul 11, 2022

press

A billion anti-covid vaccines thrown in the trash (fr)

Published by Le Temps

Jul 11, 2022

press

Over 1 billion Covid-19 vaccines could have been wasted since the global roll-out: Airfinity

Published by The Hindu BusinessLi

Jul 11, 2022

press

Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began

Published by Health Policy Watch

Jul 11, 2022

press

1.1 billion Covid vaccine doses wasted globally, estimates suggest

Published by The Independent

Jul 11, 2022

press

More than 1 billion vaccines against covid-19 were wasted (po)

Published by Valor Econômico

Jul 11, 2022

press

More than 1bn Covid vaccine jabs wasted in pandemic, says Airfinity

Published by Financial Times

Jul 10, 2022

press

WTO faces new battle over COVID tests, drugs

Published by Reuters

Jul 7, 2022

June 2022

May 2022

April 2022

press

COVID-19 Oral Antivirals Expected to Generate USD 32.5 Billion in 2022

Published by Pharma Boardroom

Apr 28, 2022

press

Moderna investors reject proposal to transfer vaccine tech

Published by Financial Times

Apr 27, 2022

press

How China got its Covid policy wrong as millions shunned homegrown vaccine

Published by The Telegraph

Apr 26, 2022

press

Roche/diagnostics: Covid vaccine victory means test makers take a rest

Published by Financial Times

Apr 25, 2022

press

Pfizer's Covid Pill Is Poised to Be Among the Fastest-Selling Treatments of All Time

Published by Bloomberg

Apr 22, 2022

press

‘We are drowning in vaccine.’ What will revive the market for Covid jabs?

Published by Financial Times

Apr 22, 2022

press

Pfizer to add nearly $24 billion revenue with COVID-19 pill in 2022 - Airfinity

Published by Seeking Alpha

Apr 22, 2022

press

Scientists urge China to replace its faltering Covid vaccines

Published by Financial Times

Apr 20, 2022

press

Why did BioNTech stock slip today? Risk of COVID-19 breakthrough cases

Published by Seeking Alpha

Apr 18, 2022

press

Pfizer draws skeptics amid concerns over outlook for COVID-related sales

Published by Seeking Alpha

Apr 17, 2022

press

Valneva/Covid: the going gets ever harder for vaccine laggards

Published by Financial Times

Apr 15, 2022

press

China was the world’s biggest Covid-19 vaccine exporter. Not any more

Published by South China Morning

Apr 14, 2022

press

Africa must learn lessons from failure to distribute Covid-19 vaccines, report finds

Published by The Telegraph

Apr 14, 2022

press

Vaccine business slows down in 2022 due to lower demand for booster doses

Published by Cinco Días

Apr 12, 2022

press

Vaccine supply exceeds demand

Published by The Manila Times

Apr 11, 2022

press

Covid-19: despite a large stockpile of vaccines, massive inequalities in distribution persist

Published by Le Temps

Apr 11, 2022

press

Demand for COVID-19 shots falls amid reluctance to boosters

Published by Seeking Alpha

Apr 10, 2022

press

How is the vaccination situation around the world? Too many doses and a lack of logistics

Published by O Globo

Apr 10, 2022

press

Demand for Covid vaccines falls amid waning appetite for booster shots

Published by Financial Times

Apr 10, 2022

press

A Key Drug in Fighting Covid Is Now at Risk

Published by Bloomberg

Apr 6, 2022

press

In a Sign of Easing Pandemic, Vaccine Doses Are Turned Down

Published by Bloomberg

Apr 6, 2022

Newsroom

In the News

China Is Stuck With Its Zero-Covid Policy Because of Weak Vaccines

Nose and mouth COVID-19 vaccines: a hundred in the pipeline

Omicron boosters are a key milestone, but aren’t likely to woo new investors to Pfizer, Moderna

China and India approve nasal COVID vaccines — are they a game changer?

How nasal-spray vaccines could change the pandemic

Bavarian Nordic earned 15.7 million for its monkeypox vaccine in the second quarter of the year

Airfinity estimates a shortage of up to 55 million monkeypox vaccine doses

Moderna sues Pfizer and BioNTech

Moderna accuses BioNTech/Pfizer of copying mRNA technology

Moderna accuses BioNTech/Pfizer of copying mRNA technology

World Monkeypox Cases Fall, Led by Decline in Europe

Thousands of retired doctors ‘must stay on’ to help with jabs

Monkeypox Vaccine Maker Seeks Partners in Race to Meet Demand

Is There Life After the Vaccine Bonanza?

Is there enough monkeypox vaccine to go around? Maybe yes, more likely no

Long-COVID treatments: why the world is still waiting

Protective treatment for Covid-19 makes minimal impact

As Healthcare Crises Pile Up, Pharma Struggles to Meet Demand

After Declaring Emergency – US Weighs Intradermal Monkeypox Vaccine Injections to Stretch One Dose into Five

Oxford vaccine saved most lives in its first year of rollout

SK Bioscience seeks approval for COVID vaccine in Europe

BioNTech-Aktie, Bavarian Nordic-Aktie & Co: According to new estimates, demand for vaccines is increasing significantly (de)

AstraZeneca ‘saved’ six million lives with Covid vaccine

3 Key Questions That Pfizer Will Answer This Week

China just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid

Pfizer’s anti-COVID pill — used by Biden — is expected to rake in $23.2 billion, but confusion and weak demand could cause supply glut

Slow patient uptake of Pfizer’s Covid drug hints at end to sales boom

Weak Demand For Covid Antivirals Dampens Roaring Sales

Wasted vaccines, over a billion unused doses: expired doses donated to poor countries

After Q2 Significant Drop, Pfizer and Moderna COVID-19 Vaccine Revenues to Rebound

Covid, vaccine decline and Pfizer and Moderna's accounts

Analysis: 1.1 billion doses of covid 19 vaccine may have been wasted

Vaxzevria 73% effective at preventing Omicron-related infections after fourth dose, according to real world evidence study in Thailand

Europe Can’t Shake Off Covid as Variant Fuels Summer Spike

Covid Vaccine Sales Projected to Pick Up After Steep Drop

A riskier approach to new vaccines will pay off

Worst backslide in global vaccinations ‘in a generation,’ U.N. says

Which covid-19 vaccine saved the most lives in 2021?

China's COVID-19 vaccine exports saved 3m lives, says UK study

Vaxzevria shown in expert review to provide equally effective protection against COVID-19 hospitalisation and death as mRNA vaccines

Astra’s Covid Vaccine Saved Over Six Million Lives in First Year

Monopolies Are Getting in the Way of mRNA Vaccines

A billion anti-covid vaccines thrown in the trash (fr)

Over 1 billion Covid-19 vaccines could have been wasted since the global roll-out: Airfinity

Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began

1.1 billion Covid vaccine doses wasted globally, estimates suggest

More than 1 billion vaccines against covid-19 were wasted (po)

More than 1bn Covid vaccine jabs wasted in pandemic, says Airfinity

WTO faces new battle over COVID tests, drugs

Generic manufacturers have already produced more than 2.5 million doses of MSD's Covid pill

EU regulator considers clearing smallpox shot for monkeypox

EU Regulator Considers Clearing Smallpox Shot For Monkeypox

UK among worst offenders in G7 vaccine supply failures ‘which led to 600,000 preventable deaths’

Britain has delivered just 39pc of Covid vaccines promised to poorer countries

Is monkeypox an international public-health emergency?

UK prepares to include over-50s in autumn Covid booster campaign

WHO to share vaccines to stop monkeypox amid inequity fears

WHO to share vaccines to stop monkeypox amid inequity fears

European Commission purchases 110,000 monkeypox vaccines

Waiving intellectual property rights is a flawed solution to achieving Covid-19 vaccine equity

Bavarian Nordic raises 2022 revenue forecast by 6.6% on demand for monkeypox vaccine

Monkeypox: Spread Continues as Moderna Explores New Vaccines

Inflation, Oil Prices, Monkeypox and Biden-Powell Meet (The Cable Podcast)

Switzerland to destroy 620,000 expired Covid vaccine doses

Pfizer warns on ‘constant waves’ of Covid-19 as complacency grows

Where is monkeypox spreading fastest?

Airfinity live on stage at FT US Pharma and Biotech Summit 2022

Pfizer to seek US emergency approval of Covid vaccine for under 5s

EU States Eye Supply Deal Shakeup as Covid Vaccine Demand Wanes

UK’s autumn Covid booster campaign could exclude most Britons

NYC Raises Covid-19 Alert Level, Advises Masks

Pfizer and Moderna to manufacture 500 million Omicron targeting doses

BioNTech beats forecasts on back of Covid vaccine demand

China's vaccine diplomacy spoiled by omicron variant

Kids get limited COVID protection from world’s most popular vaccines

Moderna targets autumn release for Omicron vaccine

Pfizer Falls as Covid Pill Fails in Preventive Therapy Trial

COVID pill falls short in trial; Pfizer's shares drop as a result